These receptors and surface markers confer the capability of acting against cells that do not display the major histocompatibility complex, as has been shown by the ability to cause lysis in non-immunogenic, allogeneic and syngeneic tumors.
These receptors and surface markers confer the capability of acting against cells, as has been shown by the ability to cause lysis in non-immunogenic, allogeneic and syngeneic tumors. These cells do not display the major histocompatibility complex.